NONOF - Novo Nordisk buys 2seventy bio's Hemophilia A program
2024-06-27 06:56:19 ET
More on Novo Nordisk
- Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk hypertension candidate ocedurenone fails in phase 3
- GLP-1 weight loss meds + exercise seen preserving bone health